The eastern woodchuck and the woodchuck hepatitis virus (WHV) are currently under investigation as a naturally occurring model system for hepatitis B virus (HBV) infection in humans. Both WHV and HBV are characterized by similar structural and genomic compositions (9, 11, 12, 28, 29) , and infection with either virus can lead to analogous pathology in their respective hosts (22, 26, 27, 29, 30, 31 ). An important marker for the study of HBV infection in humans has been the detection of viral core antigen in liver biopsies (1, 5, 35) . In conjunction with serum antigen and antibody profiles, the status of hepatitis B core antigen in liver tissue is useful in defining the clinical status of disease in humans and chimpanzees (2, 5, 14, 16, 17) , and also as a prognostic marker of disease outcome after antiviral therapy (10, 32) . Because WHV infection of woodchucks is also associated with disease sequelae (22) , the characterization of changes in WHV markers after infection is required to further define the utility of this system as a model for HBV-induced liver disease in humans. In the present study, woodchuck anticore antibody (anti-WHc) responses and woodchuck hepatitis virus core antigen (WHcAg) expression in the liver were characterized after WHV infection.
MATERIALS AND METHODS Animals. Woodchucks (Marmota monax) were maintained in a colony established in 1978 by the National Institute of Allergy and Infectious Diseases (NIAID) (Meloy Laboratories, Inc., Rockville, Md.). The 8) . For woodchucks, the inoculum was diluted 1:1,000 and administered intravenously via the femoral vein as a 0.2-ml dose. For the chimpanzee, the inoculum was diluted 1:10 and injected as a 1-ml dose via the cephalic vein. Pool B was a gift of R. L. Synder (Penrose Laboratory, Philadelphia Zoo). The inoculum was diluted twofold and administered intravenously as a 0.5-ml dose.
Sera and liver biopsies. Sera were obtained from colony woodchucks on a routine basis or weekly in conjunction with experimental protocols. Sera from an additional 16 chronic carrier woodchucks were supplied by the Cocalico woodchuck farm (Dutchland/Hazelton Laboratories, Denver, Pa.). Sera were stored at -70°C until assays were performed. Liver biopsies were obtained at selected times from animals under anesthesia, using an 18-gauge Menghini needle. Liver biopsies were obtained for immunofluorescence and electron microscopy (see below).
Electron microscopy. For electron microscopy, a portion of each liver sample was fixed with 2.5% glutaraldehyde in cacodylate buffer, postfixed in 1% osmium tetroxide, embedded in Epon, and stained with uranyl acetate and lead citrate.
Direct immunofluorescence. Serial bleedings from a WHV chronic carrier woodchuck having high titers of anti-WHc were pooled and centrifuged (5 h, 40,000 rpm, 4°C, 50 Ti Beckman rotor). The immunoglobulin fraction of the supernatant was prepared by ammonium sulfate salt precipitation (40%, 30 min, 4°C, pH 7.0) and dialysis against a carbonatebicarbonate buffer (pH 9.5). The protein concentration was adjusted to approximately 10 mg/ml, and the preparation was conjugated with fluorescein isothiocyanate ( The anti-WHc titer was the final serum dilution producing 50% inhibition of binding of the iodinated probe. RESULTS Specificity and use of the immunofluorescence test for core antigen. The specificity of the immunofluorescence (IF) test was shown by complete inhibition of fluorescence staining of a standard liver substrate with high-titer anti-WHc serum and by adsorption of FITC-conjugated anti-WHc activity with a core antigen-rich preparation from infected woodchuck liver. The activity was not adsorbed by preparations made from uninfected liver. Furthermore, kidney, pancreas, spleen, and gonads from a WHV chronic carrier woodchuck were not stained with the FITC anti-WHc (data not shown). In addition, the same anti-WHc preparations were used in the RIAs for WHcAg and anti-WHc, and no cross-reactivity with WHsAg and anti-WHs was detected (Ponzetto et al., submitted for publication).
Two hundred liver specimens collected from 57 woodchucks were examined for core antigen by IF. Livers of uninfected and convalescent woodchucks were WHcAgnegative, whereas the antigen was demonstrated in more than 80% of the animals undergoing acute and chronic infections (8 of 10 and 14 of 17, respectively). Hepatitis B core antigen-positive chimpanzee livers were not stained by the FITC anti-WHc; however, WHcAg was stained weakly in some woodchuck livers with an FITC hepatitis B core antibody conjugate (13) .
Distribution of core antigen in hepatocytes. Core antigen was present almost exclusively in the cytoplasm of hepatocytes from chronic carrier woodchucks and from wood- chucks undergoing acute infection. The fluorescence staining was of a fine granular type throughout the entire cytoplasm, sometimes appearing confluent over the entire cell (Fig. 1A  to D) . Perinuclear fluorescence without staining of the remaining cytoplasm was observed in early acute cases. The perinuclear ring disappeared with progression of the disease, which was characterized by a more diffuse staining pattern. As a rule, nuclei were stained only faintly in hepatocytes of animals undergoing acute infections and were negative in chronic carriers. These observations were confirmed by electron microscopy; the core structures were found throughout the cytoplasm in association with the endoplasmic reticulum (Fig. 2) Fig. 3 ; the serum WHsAg and anti-WHs profiles of this animal were described previously (34) . The animal developed serum WHsAg by week 6, followed by seroconversion to anti-WHs. WHs antigenemia was associated with the appearance of intrahepatic WHcAg, although liver WHcAg was detected over a somewhat longer period of time compared with that of serum WHsAg. The latter may be due to a greater protraction of liver WHcAg expression relative to WHs antigenemia or to a greater sensitivity of the former assay. Both liver WHcAg and serum anti-WHc were detected during the period of WHs antigenemia. Liver WHcAg disappeared coincident with seroconversion to anti-WHs. In this animal, anti-WHc preceded the appearance of anti-WHs, analogous to the hepatitis B core and surface antibody patterns in human HBV infection (15) . In a second animal inoculated with the same WHV pool, surface antigenemia was not detected, but the woodchuck developed brisk antibody responses to the core and surface antigens starting at weeks 5 and 12, respectively (data not shown); liver core antigen was detected by IF at both 6 and 7 weeks postinoculation. Thus, serum anti-WHc was a more sensitive indicator of WHV infection than was serum WHsAg.
Two additional woodchucks were inoculated with the WHV pool B (Fig. 4) . Again, only one of the two woodchucks developed WHs antigenemia (Fig. 4A) ulation sera were negative for anti-WHc. Low levels of antiWHc activity (1:10 titer) were detected in both animals at 2 weeks postinoculation; these levels decreased passively and probably represented anti-WHc acquired from the relatively large volume of the pool B inoculum. The subsequent rise in anti-WHc titers in both woodchucks indicated successful transmission of WHV; the titers of anti-WHc at weeks 20 ( Fig. 4A) and 24 (Fig. 4B) anti-WHc are good indicators of ongoing WHV infection in the woodchuck animal model.
A survey of colony woodchucks revealed that endpoint titers for anti-WHc were higher in animals with chronic and acute phase infections than in those convalescent or recovered from WHV infection. Twenty-eight chronic WHV carrier woodchucks had anti-WHc titers between 10-4 and 10-6. Twenty-eight WHsAg-negative woodchucks with antiWHs (recovered animals) had anti-WHc titers between 10-1 and 10-3, with only one such animal having a titer approaching . Three woodchucks in the late phase of an acute experimental WHV infection (convalescent animals) had anti-WHc titers of 10-4 (Fig. 6 ).
Apparent experimental transmission of WHV to a chimpanzee. The standard WHV inoculum shown to be infectious in woodchucks at a 10-3 dilution (pool A) was diluted 1:10 and administered in 10-fold-greater volume to an HBV-seronegative chimpanzee. Surface antigenemia was not evident, but the animal developed anti-WHc and then anti-WHs, suggesting productive but subclinical WHV infection (Fig. 7 ). There were no changes in serum enzymes in this animal. The sera were not reactive in the Corab and Ausab assays.
DISCUSSION
IF analysis and electron microscopy demonstrated that WHcAg was located predominantly in the cytoplasm of WHV-infected hepatocytes. This feature contrasts in part with that found in HBV infection of primates, in which core particles are found primarily in the hepatocyte nuclei (1, 14, 17) . The greater cytoplasmic expression of WHcAg could indicate more rapid coupling between core assembly and the exit of assembled core particles from the nucleus in the woodchuck model. Hepatitis B core antigen has been observed occasionally in the cytoplasm of infected human hepatocytes by either IF or electron microscopy (19, 21, 23, 35, 36) ; also, in situ hybridization studies have shown that HBV DNA is found in the hepatocyte cytoplasm (6) . This probably reflects assembly of HBV virion in the cisternae of the endoplasmic reticulum (19, 36 (34) . associated DNA polymerase found in sera of chronic WHV carrier woodchucks compared with chronic HBV carrier chimpanzees and humans (24) .
The percentage of core antigen-positive liver biopsies from chronically infected woodchucks (82%) was somewhat higher than that found overall among chronic HBV carriers (14, 23) . In humans, chronic HBV infection may be inactive or active, the latter form being characterized by persistent virion-associated DNA polymerase in the circulation. A high percentage of patients with chronic active HBV infections express liver core antigen (1, 14) . We and others have found that DNA polymerase persists in the circulation of chronic carrier woodchucks (22, 24) and that a high percentage of these animals demonstrate liver core antigen. Therefore, the chronic hepatitis found in the woodchuck more closely resembles the aggressive form of chronic type B hepatitis of humans (type IV according to Bianchi and Gudat [5] (34) (Fig.  4A) , the response was detected by a recently developed radioimmune precipitation assay employing 125I-labeled WHsAg and rabbit anti-woodchuck immunoglobulin G (25); the first anti-WHs was noted 2 weeks after WHs antigenemia and the initial rise in serum anti-core titer. Moreover, the core-anti-core window demonstrated in one naturally infected woodchuck (Fig. 5) resulted from a delay in the anti-WHs response after WHs antigenemia. The core-anti-core window has been observed in the chimpanzee model of HBV infection (2, 3) and is also typical of acute HBV infections in humans.
It appears that serum anti-WHc can serve as a useful marker to indicate both ongoing and prior WHV infection when liver core antigen is not assessed or detected. For example, not all WHV-infected woodchucks having antiWHc had detectable WHcAg in the liver; the latter may be related to differences in detection sensitivities, sampling of core-negative regions of the liver, or virus dose. Also, we show that higher endpoint titers for anti-WHc are evident during chronic phase infection as compared with the recovery period (Fig. 6) . Thus, the detection of anti-WHc (or a rise in anti-WHc titer) represents a useful indicator of successful WHV transmission, which obviates the need for invasive biopsy techniques. The overall observations correlate well with those found in chimpanzees infected with HBV (2, 3, 16) , and, therefore, further support the usefulness of the WHV system in modeling HBV infection in humans.
The seroconversion to anti-WHc by a chimpanzee inoculated with the WHV was presumed to indicate successful transmission. Liver biopsies were not available for observation, and the lack of detectable surface antigenemia and of increased serum enzymes suggested that the animal experienced a subclinical infection. Although cross-reactivities between the major antigen-antibody systems of WHV and HBV have been reported (7, 8, 11, 13, 33) , we did not detect cross-reactive antibodies in this chimpanzee when we used the commercial HBV RIA systems. The antibody responses of the chimpanzee, detected by the present woodchuckspecific RIAs (25, 34; Ponzetto et al., submitted for publication), indicated that the responses were specific for WHV infection. The apparent susceptibility of this single chimpanzee to WHV would be the first demonstration of interspecies cross-infectivity among hosts of the hepadnavirus family. In all likelihood, the potential susceptibility of primates to WHV infection has little epidemiological significance for humans; however, precautions should be taken in the handling of WHV infectious material until further studies on WHV host range are completed. 
ACKNOWLEDGMENTS

